What category is abciximab?: Understanding this Glycoprotein IIb/IIIa Inhibitor
•
4 min read
Before its discontinuation in 2019, abciximab was a groundbreaking antiplatelet agent widely used in cardiology to prevent thrombotic complications during percutaneous coronary intervention (PCI). A specific question that arises is **what category is abciximab**, and the answer reveals its unique pharmacological nature and historical significance.
